SPARK Impact fund invests in drug discovery company
The North West Fund for Biomedical, the £25 million fund managed by SPARK Impact, has invested £350,000 into drug discovery company Molplex Ltd.
News
The North West Fund for Biomedical, the £25 million fund managed by SPARK Impact, has invested £350,000 into drug discovery company Molplex Ltd.
News